GlassScriptPhysician profile
William W Thomas
NPI 1801358163
$1,323.82
in general payments reported to CMS, 2019-2025
18 companies · $34.79 in 2025
The $34.79 reported for 2025 was less than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $1,289 · 2025: $34.79.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,324.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,323.82 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $344.23 | 2024 | Xarelto |
| Astrazeneca Pharmaceuticals LP | $254.44 | 2024 | Breztri, Airsupra |
| Boehringer Ingelheim Pharmaceuticals, INC. | $216.42 | 2024 | Jardiance, Synjardy, Tradjenta |
| Boston Scientific Corporation | $100.70 | 2024 | Watchman Flx |
| Exact Sciences Corporation | $84.63 | 2024 | Cologuard Collection Kit |
| Pacira Pharmaceuticals Incorporated | $34.79 | 2025 | Exparel |
| Abiomed | $34.65 | 2024 | Impella |
| Lilly USA, LLC | $33.34 | 2024 | Jardiance, Zepbound |
| Amgen INC. | $32.29 | 2024 | Repatha, Otezla |
| Pfizer INC. | $29.23 | 2024 | |
| Glaxosmithkline, LLC. | $29.18 | 2024 | Trelegy Ellipta, Shingrix, Arexvy |
| Abbott Laboratories | $22.58 | 2024 | Freestyle Libre 3 |
| Axsome Therapeutics, INC. | $22.25 | 2024 | Auvelity |
| Dexcom, INC. | $20.09 | 2024 | Dexcom G6 Transmitter |
| Axonics, INC. | $19.43 | 2024 | Axonics |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Esperion Therapeutics, INC. | $15.96 | 2024 | Nexletol |
| Kowa Pharmaceuticals America, INC. | $15.64 | 2024 | Livalo |
| Abbvie INC. | $13.97 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Thomas listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.